Abstract

Limited substrates content is a major hurdle dampening the antitumor effect of catalytic therapy. Herein, a two-dimensional interplanar heterojunction (FeOCl/FeOOH NSs) with ·OH generation under ultrasound irradiation is fabricated and utilized for catalytic cancer therapy. This interplanar heterojunction is prepared through replacing chlorine from iron oxychloride with hydroxyl. Benefiting from the longer hydroxyl bond length and enhanced affinity with water, the alkali replacement treatment integrates interplanar heterojunction synthesis and exfoliation in one step. In particular, a build-in electric field facilitated Z-scheme interplanar heterojunction is formed due to the aligning Fermi levels. The holes on the valence band of FeOCl have great ability to catalyze O2 evolution from H2O, meanwhile, the generated O2 is immediately and directly reduced to H2O2 by the electrons on the conductive band of FeOOH. The self-supplying H2O2 ability guarantees efficient ·OH generation via the Fenton-like reaction catalyzed by FeOCl/FeOOH NSs, which exhibits excellent anti-tumor performance.

Chemodynamic therapy relies on Fenton or Fenton-like reactions to produce hydroxyl radical in the tumor region. Here the authors design a two-dimensional interplanar heterojunction with in situ hydroxyl radical generation under ultrasound irradiation, showing anti-cancer activity in preclinical models.

Details

Title
Design of a two-dimensional interplanar heterojunction for catalytic cancer therapy
Author
Kang, Yong 1   VIAFID ORCID Logo  ; Mao Zhuo 1 ; Wang, Ying 2 ; Pan, Chao 1 ; Ou Meitong 2 ; Zhang Hanjie 3 ; Zeng Weiwei 3 ; Ji Xiaoyuan 1 

 Tianjin University, Academy of Medical Engineering and Translational Medicine, Medical College, Tianjin, China (GRID:grid.33763.32) (ISNI:0000 0004 1761 2484) 
 Sun Yat-sen University, School of Pharmaceutical Sciences (Shenzhen), Guangzhou, China (GRID:grid.12981.33) (ISNI:0000 0001 2360 039X) 
 Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin Key Laboratory of Biomedical Materials, Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy, Institute of Biomedical Engineering, Tianjin, China (GRID:grid.506261.6) (ISNI:0000 0001 0706 7839) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2658984752
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.